Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity (Q37657640)
Jump to navigation
Jump to search
scientific article published on 22 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity |
scientific article published on 22 February 2017 |
Statements
1 reference
Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity (English)
1 reference
Arjan W Griffioen
Patrycja Nowak-Sliwinska
Robert H Berndsen
Andrea Weiss
U Kulsoom Abdul
22 February 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference